NOVO-NORDISK A/S-SPONS ADR (NVO)

Interesting NVO Put And Call Options For February 2025

Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming Abundantly More Clear.

Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for investors.

Down 19% in 1 Day, Is Novo Nordisk Stock Still a Buy?

Better Buy: Eli Lilly or Novo Nordisk?

Novo Nordisk stock crashed 17% on Friday after revealing disappointing trial results.

Market Monitor December 20

The US stock markets closed higher after a volatile day caused by triple witching day, during which the expiration of options led to increased fluctuations.

Is Merck the Next Big Weight-Loss Stock?

3 Fantastic Stocks That Could Enjoy a Santa Claus Rally

Santa Claus will soon be on his way delivering presents to kids around the world. Three Motley Fool contributors think they've identified fantastic stocks that could be in a good position to benefit from a Santa Claus rally. Here's why they chose AbbVie (NYSE: ABBV), Novo Nordisk (NYSE: NVO), and Vertex Pharmaceuticals (NASDAQ: VRTX).

3 Fantastic Stocks That Could Enjoy a Santa Claus Rally

Is Now a Good Time to Buy the Dip in Eli Lilly Stock?

Since Eli Lilly reported third-quarter earnings on Oct. 30, its shares have had a prolonged sell-off.

Why Viking Therapeutics Tumbled by More Than 10% This Week

Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up

Today's sell-off in Novo Nordisk may be the buying opportunity you've been waiting for.

Stock Market Tumbles, Treasury Yields Soar On Fed Rate Outlook: Weekly Review

Micron, Vertex, Novo Nordisk and Nike were notable losers on news.

Novo-Nordisk Enters Oversold Territory (NVO)

Novo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump.

Eli Lilly and Viking Therapeutics jumped on Novo's setback.

IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List

Compounders now have until late March to wind down their operations, depending on their licensing.

Got $250? 2 Healthcare Stocks to Buy and Hold Forever

21% of Warren Buffett's "Secret" Portfolio Is Invested in These 3 ETFs. Are They Great Picks for 2025?

This Is Huge News for Eli Lilly Investors

Eli Lilly just gave investors several reasons to cheer.

Lennox To Join S&P 500 Index, Replacing Catalent

Lennox, an AI cooling play, will join the S&P 500 before the open on Dec. 23. Bill Holdings will take its pace in the S&P Midcap 400.

Despite its growth, NYSE:NVO remains within the realm of affordability.

NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) stands out as a growth opportunity that won't break the bank.